S&P Futures
4,265.75 +1.00 (+0.02%) Dow Futures
33,233.00 +32.00 (+0.10%) Nasdaq Futures
14,703.00 -11.50 (-0.08%) Russell 2000 Futures
1,740.50 -1.40 (-0.08%) Crude Oil
88.29 -0.94 (-1.05%) Gold
1,837.90 -3.60 (-0.20%)
Shockwave Medical, Inc. (SWAV)
After hours:
Chart Events
Performance Outlook
| Previous Close | 196.31 |
| Open | 193.38 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 900 |
| Day's Range | 188.27 - 195.00 |
| 52 Week Range | 172.50 - 320.54 |
| Volume | |
| Avg. Volume | 531,865 |
| Market Cap | 7.209B |
| Beta (5Y Monthly) | 0.98 |
| PE Ratio (TTM) | 31.96 |
| EPS (TTM) | 5.95 |
| Earnings Date | Nov 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 278.20 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for SWAV
Related Research
- ShockWave Medical, Inc.SWAV: Lowering target price to $157.00SHOCKWAVE MEDICAL INC has an Investment Rating of SELL; a target price of $157.000000; an Industry Subrating of Medium; a Management Subrating of Low; a Safety Subrating of Medium; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of Low.RatingFair ValueEconomic Moat7 days agoArgus Research
Motley Fool3 Healthcare Stocks to Keep an Eye On
Shockwave Medical (NASDAQ: SWAV), Bio-Techne (NASDAQ: TECH), and Ginkgo Bioworks (NYSE: DNA) may not be well-known to a lot of investors, but all three healthcare stocks could double over the next few years thanks to their strong growth potential. The reason these three may not be familiar names is that they don't sell their products to the general public, but instead to healthcare professionals and pharmaceutical companies. Bio-Techne and Ginkgo Bioworks are good examples of pick-and-shovel companies in the gene-editing industry, while Shockwave Medical sells its products to healthcare systems for their use on patients.
GuruFocus.comInsider Sell: Isaac Zacharias Sells 4,000 Shares of ShockWave Medical Inc
On September 26, 2023, President and Chief Commercial Officer Isaac Zacharias sold 4,000 shares of ShockWave Medical Inc (NASDAQ:SWAV).
Insider MonkeyMultiple Tailwinds Pushed Shockwave Medical (SWAV) in Q2
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter. A copy of the same can be downloaded here. In the second quarter, the strategy underperformed the Russell 2000 Growth Index and returned 2.50% (net), and the index return was 7.05%. Consumer Staples, Health Care, Industrials, and Information […]
